Ihuman (IH) Stock Price
Ihuman Price
Revenue has compounded at 29.5% per year over the past 7 years to 807.02 M USD. Earnings per share have grown at 64.6% per year over the last 3 years. Ihuman's net margin stands at 11.8%, up from -3.9% several years earlier.
Ihuman stock price
Ihuman business model & stock analysis
Frequently asked questions about Ihuman
9 analysts currently rate the Ihuman stock: 8 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Ihuman share trades at 1.03 EUR (1.15 USD).
The revenue cannot currently be calculated for Ihuman.
The profit cannot currently be calculated for Ihuman.
The P/E ratio cannot be calculated for Ihuman at the moment.
The P/S cannot be calculated for Ihuman currently.
The Eulerpool Quality Score for Ihuman is 1/10.
The ISIN of Ihuman is US45175B1098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Ihuman is IH. The ticker symbol is used to trade Ihuman shares on the stock exchange.
Ihuman stock
Ihuman Peer Group
All fundamentals and in-depth analysis of Ihuman
Our stock analysis for Ihuman stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ihuman. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.